0001493152-20-014611.txt : 20200804
0001493152-20-014611.hdr.sgml : 20200804
20200804184718
ACCESSION NUMBER: 0001493152-20-014611
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200803
FILED AS OF DATE: 20200804
DATE AS OF CHANGE: 20200804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levine Mitchell S
CENTRAL INDEX KEY: 0001383492
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 201074854
MAIL ADDRESS:
STREET 1: ONE FERRY BUILDING, SUITE 255
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoCyte Corp
CENTRAL INDEX KEY: 0001642380
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 271041563
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-409-7600
MAIL ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Oncocyte Corp
DATE OF NAME CHANGE: 20200205
FORMER COMPANY:
FORMER CONFORMED NAME: OncoCyte Corp
DATE OF NAME CHANGE: 20150513
4
1
ownership.xml
X0306
4
2020-08-03
0
0001642380
OncoCyte Corp
OCX
0001383492
Levine Mitchell S
15 CUSHING
IRVINE
CA
92618
0
1
0
0
Chief Financial Officer
Common Stock, no par value
2020-08-03
4
P
0
10000
1.32
A
36579
D
2,500.000 shares purchased at $1.3165; 2,500.000 shares purchased at $1.3058; 2,500.000 shares purchased at $1.3169; and 2,500.000 shares purchased at $1.3425.
/s/ Mitchell S. Levine
2020-08-04